Hennssy Cp Aq II Wrt (HCACW) 0.31 $HCACW Hennessy

New Post Public Reply Private Reply Replies (0) Message Board

Jun 11, 2016 at 3:01 PM

Hennssy Cp Aq II Wrt (HCACW) 0.31 $HCACW

Hennessy Capital Acquisition Corp. II Announces Record and Meeting Dates for Special Meeting of Stockholders to Approve Merger with USI
GlobeNewswire - Tue May 31, 7:00AM CDT
Hennessy Capital Acquisition Corp. II (NASDAQ:HCAC) (NASDAQ:HCACU) (NASDAQ:HCACW) ("HCAC" or the "Company"

today announced that the Securities and Exchange Commission (the "SEC"

has completed its review of HCAC's preliminary proxy statement and HCAC has set a record date of June 6, 2016 (the "Record Date"

and a meeting date of June 29, 2016 for the special meeting in lieu of the 2016 annual meeting of HCAC stockholders (the "Special Meeting"

to approve HCAC's proposed merger with USI Senior Holdings, Inc. ("USI"

. HCAC's stockholders of record at the close of business on June 6, 2016 are entitled to receive notice of the Special Meeting and to vote the shares of common stock of HCAC owned by them at the Special Meeting.
HCAC: 9.83 (+0.03), HCACW: 0.31 (+0.01), HCACU: 10.20 (-0.02)

Hennessy Capital Acquisition Corp. II and USI Announce Merger Agreement
GlobeNewswire - Mon Apr 04, 5:00AM CDT
Hennessy Capital Acquisition Corp. II (NASDAQ:HCAC) (NASDAQ:HCACU) (NASDAQ:HCACW) ("HCAC"

and United Subcontractors, Inc. ("USI"

today announced that they have entered into a definitive merger agreement, pursuant to which HCAC will acquire all of the outstanding capital stock of USI Senior Holdings, Inc., the indirect parent company of USI. In connection with the merger, HCAC will change its name to USI Holdings, Inc. and continue to list its common stock and warrants on the NASDAQ Capital Market under the tickers "USI" and "USIW," respectively.
STCK: 19.26 (-0.39), HCAC: 9.83 (+0.03), HCACW: 0.31 (+0.01), HCACU: 10.20 (-0.02)

Hennessy Capital Acquisition Corp. Announces Agreement in Principle by Coliseum Capital Management to Purchase $25 Million of Common Stock and $10 Million of Preferred Stock
GlobeNewswire - Tue Feb 17, 8:50AM CST
Hennessy Capital Acquisition Corp. (Nasdaq:HCAC) (Nasdaq:HCACU) (Nasdaq:HCACW) ("HCAC" or the "Company"

today announced that it has reached an agreement in principle with Coliseum Capital Management, LLC ("Coliseum"

, pursuant to which Coliseum would purchase $25 million in shares of common stock and $10 million in shares of preferred stock at or prior to the closing of the Company's previously announced acquisition of School Bus Holdings, Inc., which, through its subsidiaries, conducts its business under the "Blue Bird" name (the "Business Combination"

. The net proceeds from the sale of preferred stock, and any common stock issued in a private placement to Coliseum, will be used to finance a portion of the cash purchase price in the Business Combination.
HCAC: 9.83 (+0.03), HCACW: 0.31 (+0.01), HCACU: 10.20 (-0.02)

Hennessy Capital Acquisition Corp. Announces Agreement in Principle to Amend Blue Bird Purchase Agreement to Reduce Pro Forma Common Share Count by 5.4 Million Shares Through Decrease of Stock Consideration and Cancellation of a Portion of Founder Shares
GlobeNewswire - Mon Feb 09, 7:36PM CST
Hennessy Capital Acquisition Corp. (Nasdaq:HCAC) (Nasdaq:HCACU) (Nasdaq:HCACW) ("HCAC" or the "Company"

today announced that it has reached an agreement in principle with The Traxis Group, B.V. ("Seller"

, which is majority owned by funds affiliated with Cerberus Capital Management, L.P., to amend its previously announced purchase agreement to acquire from Seller all of the outstanding capital stock of School Bus Holdings, Inc. ("SBH"

which, through its subsidiaries, conducts its business under the "Blue Bird" name (the "Business Combination"

.
HCAC: 9.83 (+0.03), HCACW: 0.31 (+0.01), HCACU: 10.20 (-0.02)

Hennessy Capital Acquisition Corp. to Postpone Special Meeting of Stockholders to February 20, 2015 and Extend Warrant Exchange Offer Through February 26, 2015
GlobeNewswire - Fri Feb 06, 6:17PM CST
Hennessy Capital Acquisition Corp. (Nasdaq:HCAC) (Nasdaq:HCACU) (Nasdaq:HCACW) ("HCAC" or the "Company"

today announced that it will postpone its special meeting of stockholders (the "Special Meeting"

relating to its previously announced acquisition of School Bus Holdings, Inc. ("SBH"

which, through its subsidiaries, conducts its business under the "Blue Bird" name, from Seller (the "Business Combination"

, from February 9, 2015 to February 20, 2015, at 9:00 a.m., Eastern time, at the offices of Sidley Austin LLP, 787 Seventh Avenue, New York, New York 10019 and extend the deadline for HCAC stockholders to exercise their redemption rights in connection with the Business Combination to 5:00 p.m., Eastern time on February 18, 2015 (two business days before the Special Meeting). Only holders of record of Company common stock at the close of business on January 2, 2015 are entitled to vote at the Special Meeting.
HCAC: 9.83 (+0.03), HCACW: 0.31 (+0.01), HCACU: 10.20 (-0.02)

Hennessy Capital Acquisition Corp. Announces Extension of Warrant Exchange Offer
GlobeNewswire - Wed Jan 21, 4:15PM CST
Hennessy Capital Acquisition Corp. (Nasdaq:HCAC) (Nasdaq:HCACU) (Nasdaq:HCACW) ("HCAC" or the "Company"

today announced the extension of its previously announced offer to exchange (the "Offer"

up to a maximum of 5,750,000 of its outstanding warrants (the "Warrants"

for shares of Company common stock (the "Shares"

at an exchange ratio of 0.1 of a Share for each Warrant validly tendered and not withdrawn (approximately one Share for every ten Warrants tendered). The Offer has been extended until 12:00 midnight, New York City time, at the end of the day on February 13, 2015, unless further extended by the Company.
HCAC: 9.83 (+0.03), HCACW: 0.31 (+0.01), HCACU: 10.20 (-0.02)

Hennessy Capital Acquisition Corp. Commences Offer to Exchange Common Stock for Up to 5,750,000 of Its Outstanding Warrants
GlobeNewswire - Wed Jan 07, 8:00AM CST
Hennessy Capital Acquisition Corp. (Nasdaq:HCAC) (Nasdaq:HCACU) (Nasdaq:HCACW) ("HCAC" or the "Company"

today announced that it has commenced an offer to exchange (the "Offer"

0.1 of a share of HCAC common stock (the "Shares"

for each outstanding HCAC warrant exercisable for Shares at an exercise price of $5.75 per half share ($11.50 per whole Share), subject to adjustment (the "Warrants"

(approximately one Share for every ten Warrants tendered), up to a maximum of 5,750,000 Warrants.
HCAC: 9.83 (+0.03), HCACW: 0.31 (+0.01), HCACU: 10.20 (-0.02)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASTS Faces Class Action; Investors Beware of Pitfalls

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Korean 'Glocal' Districts Entice U.S. Tourists with Local Flavor

Gwangju's Dongmyeong-dong is like the neighborhood artists and hipsters flock to in New York—except it’s got a Korean twist. Nestled in the Jeonnam region, this place is hot on American tourists' radar for its spicy mix of local culture, unique eats, and shops that scream individuality. It's becoming a magnet for folks who want to get a taste of Korean life but with a...

Veterinary Stories Transform Pet Care in New Docuseries

Peeling Back the Scrubs: Hidden Heroes in Vet Medicine Everyone's all-hands-on-deck when it's your furball on the line, but how much do you really know about what happens in those vet offices? Finally, National Veterinary Associates (NVA) is unzipping that mystery with a no-bones-about-it docuseries, Advancing Veterinary Medicine: Our Stories, right out of Austin, Texas....

AI Tool Identifies PTSD in ER: Game-changer?

Pushing Boundaries: AI and Emergency Room Narratives When you think about the chaos of an emergency room, PTSD might not be the first thing that comes to mind. But for the folks developing cutting-edge AI at NYU Langone Health, it's a crucial window of opportunity. Enter PREVIA, an AI tool that’s been tapping into patients’ narratives to pinpoint PTSD risks with...

TalentNeuron and CodeSignal Team Up: Impact on Workforce

Skills Intelligence Takes Center Stage There's a fresh breeze blowing through the workforce planning domain, thanks to the newly expanded partnership between TalentNeuron and CodeSignal. They've strapped together their expertise to craft what's now touted as the most comprehensive skills intelligence available to organizations. A claim big enough to make us stop,...

Hyperscale Data Plans Major Stock Exchange Deal

Hyperscale's Bold Move: Exchange Offer Hits the Market Man, when a company believes its market value is out of whack, you get moves like this. Hyperscale Data, strutting under ticker symbol NYSE:GPUS, is swinging for the fences with an exchange offer, aiming to mop up $50 million worth of its common stock with a sweet deal that’s sure to grab any investor's attention....

Terminales Portuarios Euroandinos Paita Seeks Consent to Amend Notes

Initiating Amendments for Flexibility Terminales Portuarios Euroandinos Paita S.A., based over in Piura, Peru, has started the process of soliciting consents from holders of its 8.125% Series 2012-1 Senior TPE Secured Notes due 2037. These folks are looking to tweak the indenture tied up with Citibank N.A., trying to get some extra wiggle room in their operations. We’re...

PharmaBlock Forum: Strategic CMC Moves Crucial for Biotech

CMC Strategies: The Unsung Hero in Biotech Development Ah, the world of biotech, where one day you're a hero in the lab, and the next you're scrambling to make sense of chemistry, manufacturing, and controls (CMC). It's high time folks started realizing that CMC isn't just procedural drudgery—it's the backbone of making a promising drug go global. That's what the...

Laboratoires Pierre Fabre and XtalPi Unite for AI-Driven Drug Hunt

An Unexpected Turn in the Drug Discovery Arena It's not every day that you see a historic French pharma powerhouse and a cutting-edge Chinese tech firm join forces. On one side, we've got Laboratoires Pierre Fabre, steeped in the history and nitty-gritty of clinical drug development. On the other, we’ve got XtalPi Holdings Limited (2228.HK), bringing their high-tech AI...

Expedera Teams Up with Cadence for Edge AI Supercharge

A New Power Couple in AI Expedera and Cadence have decided to stir up the edge AI waters with their latest collaboration. By linking Expedera's Origin™ Evolution NPU with Cadence's Tensilica NeuroEdge 130 AI Co-Processor, we're looking at a partnership that's hell-bent on redefining efficiency and performance in edge AI systems. Breaking Down the Collaboration This...